Hostname: page-component-7bb8b95d7b-dtkg6 Total loading time: 0 Render date: 2024-09-21T02:14:48.084Z Has data issue: false hasContentIssue false
  • English
  • Français

Introduction

Published online by Cambridge University Press:  22 August 2007

David Ames
David Ames*
Affiliation:
Editor, University of Melbourne, Australia Email: ipaj-ed@unimelb.edu.au
Get access Rights & Permissions [Opens in a new window]

Extract

Does the pharmaceutical industry exert excessive influence on prescribing, research and publication in the field of psychogeriatrics? This is a topic about which I receive a significant number of emails and one which often gets discussed when those active in research in our discipline get together (at both sponsored and unsponsored events!).

Type
For Debate
Information
International Psychogeriatrics , Volume 19 , Issue 6 , December 2007 , pp. 1003
Copyright
Copyright © International Psychogeriatric Association 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)